Mkts

Syndax Pharmaceuticals, Inc.

NASDAQ: SNDX
$9.55+0.01 (+0.10%)
As of Nov 9, 4:00 PM ET

Key statistics

Day range
9.149.75
52-week range
9.2225.59
Today
Open9.68
Previous close9.55
Volume—
Valuation
Market cap870.12M
P/E ratio—
EPS (TTM)-2.37
Income & risk
Dividend / yield—
Beta0.43
Avg volume2.15M
Discussion

SNDX News

Stories mentioning SNDX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue64,86468,48145,87137,95820,0427,68012,5003,500
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development58,84578,64156,28062,22761,63665,52970,97148,655
Sales General & Admin
Total Operating Expenses99,066131,029103,297107,311103,799104,045102,07777,716
Operating Income (Loss)(34,202)(62,548)(57,426)(69,353)(83,757)(96,365)(89,577)(74,216)
Interest Income3,5614,3285,2695,9507,1837,1085,4426,284
Interest Expense45.00
Other Expense(186.00)(275.00)(221.00)(106.00)32.00(86.00)
Pretax Income
Tax Provision0.000.00
Net Income (Loss)(42,673)(68,014)(60,715)(71,847)(84,846)(94,169)(84,126)(68,063)
Earnings Per Share (Basic)(0.48)(0.79)(0.70)(0.83)(0.98)(1.10)(0.98)(0.80)
Earnings Per Share (Diluted)(0.48)(0.79)(0.70)(0.83)(0.98)(1.10)(0.98)(0.80)
Weighted Average Shares Outstanding (Basic)88,25686,62686,62186,33786,17285,62285,43485,275
Weighted Average Shares Outstanding (Diluted)88,25686,62686,62186,33786,17285,62285,43485,275

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About SNDX

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is a stock listed on the Nasdaq Stock Market under the ticker symbol SNDX. It last traded at $9.55 (Nov 9, 2026, 4:00 PM ET), up 0.1% on the day. That gives Syndax Pharmaceuticals a market capitalisation of $870.1M.

Over the past 52 weeks SNDX has traded between $9.22 and $25.59.

Revenue for the quarter ended Mar 31, 2026 was $64.9M; a net loss of $42.7M. Revenue was up 224% from $20.0M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$64.9M-$42.7M-65.8%
Dec 31, 2025$68.5M-$68.0M-99.3%
Sep 30, 2025$45.9M-$60.7M-132.4%
Jun 30, 2025$38.0M-$71.8M-189.3%

From Syndax Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…